EssilorLuxottica (ESLOY)
(Delayed Data from OTC)
$116.87 USD
+0.83 (0.72%)
Updated Aug 15, 2024 03:59 PM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
EssilorLuxottica Unsponsored ADR (ESLOY) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$118.00 | $118.00 | $118.00 | 1.69% |
Price Target
Only one analyst offered a short-term price target of $118.00 for EssilorLuxottica Unsponsored ADR. This represents an increase of 1.69% from the last closing price of $116.04.
Analyst Price Targets (1 )
Broker Rating
EssilorLuxottica Unsponsored ADR currently has an average brokerage recommendation (ABR) of 2.14 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 2.14 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, three are Strong Buy, representing 42.86% of all recommendations. A month ago, Strong Buy represented 42.86%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 4 | 4 | 4 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.14 | 2.14 | 2.14 | 2.14 | 2.14 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/28/2024 | Not Identified | Not Identified | Hold | Hold |
1/29/2024 | UBS | Susy Tibaldi | Hold | Hold |
12/1/2023 | Not Identified | Not Identified | Strong Buy | Strong Buy |
10/2/2023 | Not Identified | Not Identified | Strong Sell | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.14 |
ABR (Last week) | 2.14 |
# of Recs in ABR | 7 |
Average Target Price | $118.00 |
LT Growth Rate | 9.00% |
Industry | Medical - Products |
Industry Rank by ABR | 99 of 253 |
Current Quarter EPS Est: | NA |